|
As a cataract and refractive surgeon, Davis Duehr Dean Ophthalmologist Stephen Boorstein, MD, has extensive experience with astigmatism correction, and is now the first in the area to use a new innovation that can greatly decrease the dependence on glasses or contact lenses for patients with astigmatism following cataract surgery.
Astigmatism is a common condition caused by an irregularity in the curvature of the cornea, the clear covering of the front of the eye. Those with astigmatism have trouble seeing fine details from a distance, and the condition is typically treated with glasses, contacts or refractive surgery.
The new technology for cataract surgery, a type of intraocular lens implant called Acrysof Toric intraocular lens, allows Dr. Boorstein to treat astigmatism at the time of cataract surgery by placing the toric (astigmatism correcting) lens into the eye to replace the cataract-affected, cloudy lens. The new clear lens is designed to correct both nearsightedness or farsightedness (spherical power) and astigmatism (cylindrical power), something that intraocular lenses had not been able to do in the past.
“All patients who have cataract surgery also receive an intraocular lens implant. The new toric intraocular lens implant has been shown clinically to reduce or eliminate pre-existing astigmatism and to significantly improve spectacle freedom for distance following cataract surgery,” says Dr. Boorstein. “I am excited to offer the toric intraocular lens implant as this advance helps patients see more clearly postoperatively.”
Dr. Boorstein has been elected by his peers to the prestigious “Best Doctors in America” as well as being selected among “America’s Top Ophthalmologists.” Dr. Boorstein has authored numerous scientific and review articles that he has presented before both national and international communities, reviews scientific research papers for publication to Ophthalmologic journals and is active in research concerning cataract and refractive surgery. |
Specialists
